Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TransMedics (TMDX) Profit After Tax (2018 - 2025)

TransMedics has reported Profit After Tax over the past 8 years, most recently at $105.4 million for Q4 2025.

  • Quarterly results put Profit After Tax at $105.4 million for Q4 2025, up 1437.0% from a year ago — trailing twelve months through Dec 2025 was $190.3 million (up 436.6% YoY), and the annual figure for FY2025 was $190.3 million, up 436.6%.
  • Profit After Tax for Q4 2025 was $105.4 million at TransMedics, up from $24.3 million in the prior quarter.
  • Over the last five years, Profit After Tax for TMDX hit a ceiling of $105.4 million in Q4 2025 and a floor of -$25.4 million in Q3 2023.
  • Median Profit After Tax over the past 5 years was -$1.8 million (2023), compared with a mean of $6.0 million.
  • Biggest five-year swings in Profit After Tax: tumbled 242.34% in 2023 and later skyrocketed 1437.0% in 2025.
  • TransMedics' Profit After Tax stood at -$12.7 million in 2021, then surged by 46.95% to -$6.7 million in 2022, then soared by 159.99% to $4.0 million in 2023, then soared by 70.11% to $6.9 million in 2024, then skyrocketed by 1437.0% to $105.4 million in 2025.
  • The last three reported values for Profit After Tax were $105.4 million (Q4 2025), $24.3 million (Q3 2025), and $34.9 million (Q2 2025) per Business Quant data.